Genome-edited crops and biological carbon capture offer biotechnology solutions to food security and climate change. Critically analyse.
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
India's BioE3 Policy, approved by the Cabinet in August 2024, aims for high-performance biomanufacturing [6]. Under it, ICGEB New Delhi works on genome-edited crops, biological carbon capture and bio-ethanol systems [1]. These tools show real promise. They are, however, only partial solutions: regulation is still contested and scaling them up is hard.
Promise: Food security
- First genome-edited rice: ICAR announced DRR Dhan 100 (Kamala) and Pusa DST Rice 1 in 2025. Both were made with CRISPR-Cas and contain no foreign DNA [2].
- Faster approval: Since 2022, SDN-1/SDN-2 edits without foreign DNA have been exempt from the strict GM rules (Rules 7–11 of the 1989 Rules), and DBT has issued procedures for them [3]. This cuts the time from lab to field.
- Climate-resilient agriculture is a BioE3-aligned research area at ICGEB [1].
Promise: Climate change
- Carbon capture and utilisation (CCU), in which microbes turn CO₂ into useful products, and enzyme/yeast-based ethanol both support decarbonisation [1].
- Bioeconomy link: India's bioeconomy grew from $10 billion (2014) to $165.7 billion (2024). The target is $300 billion by 2030 [4].
Limitations
- Regulatory trust: Lighter rules mean less public testing. Civil-society groups alleged bias in the trials of the two rice lines, and ICAR rejected the charge [5]. Without open data, farmers and the public may not accept these crops.
- Lab-to-factory gap: Biological carbon capture is still at the research stage [1]. It needs large-scale fermentation, buyers and the planned biomanufacturing hubs [4]. For now it cannot match the scale of emission cuts.
- Thin R&D funding: GERD (total R&D spending) was 0.64% of GDP in 2020-21, against a long-standing 2% goal [7].
- Biosafety and equity: Dual-use risks (research that can be misused), patent control over seeds and access for small farmers all need safeguards.
- Not a substitute: Water, soil health and cutting fossil-fuel use remain essential.
Overall, gene editing and biological carbon capture are useful tools, but they need public trust, money and factories to work at scale. The way forward is to publish safety data for every crop released, link ICGEB's biofoundry to the BioE3 hubs, and require private co-funding before scale-up. Done this way, biotechnology can advance SDG 2 (Zero Hunger) and SDG 13 (Climate Action) in a responsible way.
Sources
- 1PIB: Dr. Jitendra Singh visits ICGEB Trieste (Nov 2026)ICGEB India's work on genome-edited crops, carbon capture, bio-ethanol and climate-resilient agriculture; BioE3 alignment
- 2PIB: Union Agriculture Minister announces two genome-edited rice varieties developed in IndiaKamala and Pusa DST Rice 1; CRISPR-Cas with no foreign DNA
- 3PIB: Notification of SOPs for regulatory review of genome-edited plants under SDN-1 and SDN-2 categories, 2022exemption from Rules 7–11; DBT procedures
- 4PIB: India — A Global Bioeconomy Powerhouse (Sep 2025)bioeconomy $10 bn to $165.7 bn, $300 bn target; biomanufacturing hubs
- 5PIB: ICAR rebuts allegations of bias in evaluation of gene-edited rice linesdispute over trial evaluation
- 6PIB: Cabinet approves Vigyan Dhara and BioE3 initiatives (Aug 2024)BioE3 approval; high-performance biomanufacturing
- 7PRS Legislative Research: Demand for Grants 2024-25 Analysis — Science and TechnologyGERD 0.64% of GDP (2020-21); 2% goal